{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T11:56:23Z","timestamp":1767182183419,"version":"build-2238731810"},"update-to":[{"DOI":"10.1371\/journal.ppat.1013018","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000}}],"reference-count":64,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015691","name":"Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI110116"],"award-info":[{"award-number":["AI110116"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001774","name":"New Jersey Health Foundation","doi-asserted-by":"publisher","award":["PC 118-24"],"award-info":[{"award-number":["PC 118-24"]}],"id":[{"id":"10.13039\/100001774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"abstract":"<jats:p>\n                    HIV-1 persists indefinitely in individuals living with HIV-1 even after effective treatment with antiretroviral therapy (ART). Upon cessation of the therapy, latently infected memory CD4+ T cells allow for a rapid rebound of the virus. The development of latency reversing agents (LRAs) to activate latent virus promoting immune recognition and clearance of the infected cells is pivotal for the elimination of the latent arm of the infection. Success of this strategy requires the development of potent highly specific LRAs with fewer off-target effects. LRA activity displayed by proteasome inhibitors although not highly specific opens the possibility of exploiting the high degree of specificity of the ubiquitin-proteasome system to develop targeted LRAs. Here we demonstrate that a small molecule GS143, which inhibits \u03b2-TrCP, the substrate recognition subunit of the SCF\n                    <jats:sup>\n                      <jats:italic>\u03b2<\/jats:italic>\n                      -TrCP\n                    <\/jats:sup>\n                    E3 ubiquitin protein ligases, exhibits potent LRA activity both in a primary cell model system of latency and cells from aviremic individuals with HIV-1 treated with ART. Furthermore, GS143 reactivates latent HIV-1 without activating T cells, a desirable attribute for LRAs of clinical use. We showed that GS143 acts in a complementary fashion with at least two other classes of LRAs, thereby representing novel drug combinations for targeting HIV-1 latency. Finally, our results suggest that GS143 triggers a novel signaling pathway to reactivate latent HIV-1 that leads to the unconventional activation of NF\u03baB p65, by initiating the noncanonical signaling via NIK, followed by activation of IKK leading to phosphorylation of p65 on S536 and its nuclear translocation. Moreover, we show that \u03b2-catenin inhibitors suppress reactivation HIV-1 by GS143, suggesting that \u03b2-catenin supports NF-\u03baB output indirectly. Overall, our results suggest that the \u03b2-TrCP E3 ligase inhibitor GS143 represents a new type of LRA.\n                  <\/jats:p>","DOI":"10.1371\/journal.ppat.1013018","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T17:56:46Z","timestamp":1743530206000},"page":"e1013018","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["GS143, an inhibitor of E3 ligase \u03b2-TrCP, reverses HIV-1 latency without activating T cells via unconventional activation of NF\u03baB"],"prefix":"10.1371","volume":"21","author":[{"given":"Srijata","family":"Sarkar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifumi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Russnak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald G.","family":"Nahass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph P.","family":"Dougherty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3947-0478","authenticated-orcid":true,"given":"C\u00e9line","family":"G\u00e9linas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,4,1]]},"reference":[{"issue":"6297","key":"ppat.1013018.ref001","doi-asserted-by":"crossref","first-page":"aaf6517","DOI":"10.1126\/science.aaf6517","article-title":"Latency reversal and viral clearance to cure HIV-1","volume":"353","author":"DM Margolis","year":"2016","journal-title":"Science"},{"issue":"4","key":"ppat.1013018.ref002","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/COH.0000000000000279","article-title":"Shocking HIV out of hiding: where are we with clinical trials of latency reversing agents?","volume":"11","author":"TA Rasmussen","year":"2016","journal-title":"Curr Opin HIV AIDS"},{"issue":"2","key":"ppat.1013018.ref003","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.tim.2015.11.003","article-title":"Reversal of Latency as Part of a Cure for HIV-1","volume":"24","author":"TA Rasmussen","year":"2016","journal-title":"Trends Microbiol"},{"key":"ppat.1013018.ref004","first-page":"1","article-title":"Novel latency reversal agents for HIV-1 cure","volume":"68","author":"AM Spivak","year":"2017","journal-title":"Annual Review of Medicine"},{"key":"ppat.1013018.ref005","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.3389\/fmicb.2019.03060","article-title":"Current status of latency reversing agents facing the heterogeneity of HIV-1 cellular and tissue reservoirs","volume":"10","author":"A Ait-Ammar","year":"2019","journal-title":"Front Microbiol"},{"key":"ppat.1013018.ref006","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1742-4690-10-120","article-title":"Proteasome inhibitors act as bifunctional antagonists of human immunodeficiency virus type 1 latency and replication","volume":"10","author":"LK Miller","year":"2013","journal-title":"Retrovirology"},{"key":"ppat.1013018.ref007","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1146\/annurev-biochem-052110-120012","article-title":"Ubiquitin and proteasomes in transcription","volume":"81","author":"F Geng","year":"2012","journal-title":"Annu Rev Biochem"},{"issue":"1","key":"ppat.1013018.ref008","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1042\/BST20150209","article-title":"Specificity and disease in the ubiquitin system","volume":"44","author":"VK Chaugule","year":"2016","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"ppat.1013018.ref009","doi-asserted-by":"crossref","first-page":"e1487","DOI":"10.1371\/journal.pone.0001487","article-title":"Genome-wide and functional annotation of human E3 ubiquitin ligases identifies MULAN, a mitochondrial E3 that regulates the organelle\u2019s dynamics and signaling","volume":"3","author":"W Li","year":"2008","journal-title":"PLoS One"},{"issue":"10","key":"ppat.1013018.ref010","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1089\/aid.2008.0284","article-title":"Short communication: RNA interference directed against Axin1 upregulates human immunodeficiency virus type 1 gene expression by activating the Wnt signaling pathway in HeLa-derived J111 cells","volume":"25","author":"M Kameoka","year":"2009","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"11","key":"ppat.1013018.ref011","doi-asserted-by":"crossref","first-page":"6273","DOI":"10.1073\/pnas.96.11.6273","article-title":"beta-Trcp couples beta-catenin phosphorylation-degradation and regulates Xenopus axis formation","volume":"96","author":"C Liu","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"ppat.1013018.ref012","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.devcel.2009.06.016","article-title":"Wnt\/beta-catenin signaling: components, mechanisms, and diseases","volume":"17","author":"BT MacDonald","year":"2009","journal-title":"Dev Cell"},{"issue":"4","key":"ppat.1013018.ref013","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.bbrc.2008.01.166","article-title":"A novel small-molecule inhibitor of NF-kappaB signaling","volume":"368","author":"H Nakajima","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"ppat.1013018.ref014","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/nar\/28.3.663","article-title":"A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter","volume":"28","author":"LA Pereira","year":"2000","journal-title":"Nucleic Acids Res"},{"issue":"11\u201312","key":"ppat.1013018.ref015","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.drudis.2012.12.008","article-title":"Targeting HIV latency: pharmacologic strategies toward eradication","volume":"18","author":"S Xing","year":"2013","journal-title":"Drug Discov Today"},{"issue":"11","key":"ppat.1013018.ref016","doi-asserted-by":"crossref","first-page":"10326","DOI":"10.1074\/jbc.M412643200","article-title":"A novel NF-kappaB pathway involving IKKbeta and p65\/RelA Ser-536 phosphorylation results in p53 Inhibition in the absence of NF-kappaB transcriptional activity","volume":"280","author":"S-J Jeong","year":"2005","journal-title":"J Biol Chem"},{"issue":"3","key":"ppat.1013018.ref017","doi-asserted-by":"crossref","first-page":"e1010354","DOI":"10.1371\/journal.ppat.1010354","article-title":"\u03b2-catenin regulates HIV latency and modulates HIV reactivation","volume":"18","author":"HJ Barbian","year":"2022","journal-title":"PLoS Pathog"},{"issue":"1","key":"ppat.1013018.ref018","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1080\/22221751.2022.2026198","article-title":"Pharmacological suppression of glycogen synthase kinase-3 reactivates HIV-1 from latency via activating Wnt\/\u03b2-catenin\/TCF1 axis in CD4+ T cells.","volume":"11","author":"J Wen","year":"2022","journal-title":"Emerg Microbes Infect"},{"issue":"4","key":"ppat.1013018.ref019","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1099\/jgv.0.000716","article-title":"Histone deacetylase inhibitors containing a benzamide functional group and a pyridyl cap are preferentially effective human immunodeficiency virus-1 latency-reversing agents in primary resting CD4+ T cells","volume":"98","author":"Y Kobayashi","year":"2017","journal-title":"J Gen Virol"},{"issue":"4","key":"ppat.1013018.ref020","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nm.3489","article-title":"New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo","volume":"20","author":"C Bullen","year":"2014","journal-title":"Nat Med"},{"issue":"9","key":"ppat.1013018.ref021","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1128\/jvi.64.9.4306-4312.1990","article-title":"Direct and cytokine-mediated activation of protein kinase C induces human immunodeficiency virus expression in chronically infected promonocytic cells","volume":"64","author":"AL Kinter","year":"1990","journal-title":"J Virol"},{"issue":"24","key":"ppat.1013018.ref022","first-page":"6846","article-title":"Isolation and structure of bryostatin-1","volume":"104","author":"G Pettit","year":"1982","journal-title":"J. Am.\u00a0Chem.\u00a0Soc"},{"issue":"7","key":"ppat.1013018.ref023","doi-asserted-by":"crossref","first-page":"e1005063","DOI":"10.1371\/journal.ppat.1005063","article-title":"An in-depth comparison of latency-reversing agent combinations in various In Vitro and Ex Vivo HIV-1 Latency models identified bryostatin-1+JQ1 and Ingenol-B+JQ1 to potently reactivate viral gene expression","volume":"11","author":"G Darcis","year":"2015","journal-title":"PLoS Pathog"},{"issue":"5","key":"ppat.1013018.ref024","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1172\/JCI80142","article-title":"Ex vivo analysis identifies effective HIV-1 latency-reversing drug combinations","volume":"125","author":"GM Laird","year":"2015","journal-title":"J Clin Invest"},{"issue":"24","key":"ppat.1013018.ref025","doi-asserted-by":"crossref","first-page":"21083","DOI":"10.1074\/jbc.M110.195537","article-title":"High-throughput screening uncovers a compound that activates latent HIV-1 and acts cooperatively with a histone deacetylase (HDAC) inhibitor","volume":"286","author":"S Micheva-Viteva","year":"2011","journal-title":"J Biol Chem"},{"issue":"6","key":"ppat.1013018.ref026","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2174\/157016210793499312","article-title":"Bryostatin-1 synergizes with histone deacetylase inhibitors to reactivate HIV-1 from latency","volume":"8","author":"M P\u00e9rez","year":"2010","journal-title":"Curr HIV Res"},{"issue":"10","key":"ppat.1013018.ref027","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1371\/journal.ppat.0030146","article-title":"HMBA releases P-TEFb from HEXIM1 and 7SK snRNA via PI3K\/Akt and activates HIV transcription","volume":"3","author":"X Contreras","year":"2007","journal-title":"PLoS Pathog"},{"key":"ppat.1013018.ref028","first-page":"5173205","article-title":"HMBA enhances prostratin-induced activation of Latent HIV-1 via suppressing the expression of negative feedback regulator A20\/TNFAIP3 in NF-\u03baB Signaling","author":"D Chen","year":"2016","journal-title":"Biomed Res Int"},{"issue":"12","key":"ppat.1013018.ref029","doi-asserted-by":"crossref","first-page":"e1003834","DOI":"10.1371\/journal.ppat.1003834","article-title":"An in-depth comparison of latent HIV-1 reactivation in multiple cell model systems and resting CD4+ T cells from aviremic patients","volume":"9","author":"CA Spina","year":"2013","journal-title":"PLoS Pathog"},{"issue":"3","key":"ppat.1013018.ref030","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1744-7348.1939.tb06990.x","article-title":"The toxicity of poisons applied jointly1","volume":"26","author":"CI Bliss","year":"1939","journal-title":"Ann. appl. Biol"},{"issue":"6114","key":"ppat.1013018.ref031","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/326711a0","article-title":"An inducible transcription factor activates expression of human immunodeficiency virus in T cells","volume":"326","author":"G Nabel","year":"1987","journal-title":"Nature"},{"issue":"3","key":"ppat.1013018.ref032","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.chom.2015.08.009","article-title":"BIRC2\/cIAP1 is a negative regulator of HIV-1 transcription and can be targeted by Smac Mimetics to promote reversal of viral latency","volume":"18","author":"L Pache","year":"2015","journal-title":"Cell Host Microbe"},{"issue":"3","key":"ppat.1013018.ref033","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.bbrc.2007.10.200","article-title":"In vitro selection of optimal RelB\/p52 DNA-binding motifs","volume":"365","author":"L Britanova","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"issue":"17","key":"ppat.1013018.ref034","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1101\/gad.9.17.2090","article-title":"Activation of the HIV-1 enhancer by the LEF-1 HMG protein on nucleosome-assembled DNA in vitro","volume":"9","author":"PL Sheridan","year":"1995","journal-title":"Genes Dev"},{"issue":"7","key":"ppat.1013018.ref035","first-page":"621","article-title":"Purification of TCF-1 alpha, a T-cell-specific transcription factor that activates the T-cell receptor C alpha gene enhancer in a context-dependent manner","volume":"2","author":"ML Waterman","year":"1990","journal-title":"New Biol"},{"issue":"10","key":"ppat.1013018.ref036","doi-asserted-by":"crossref","first-page":"e46567","DOI":"10.1371\/journal.pone.0046567","article-title":"Erioflorin stabilizes the tumor suppressor Pdcd4 by inhibiting its interaction with the E3-ligase \u03b2-TrCP1","volume":"7","author":"JS Blees","year":"2012","journal-title":"PLoS One"},{"issue":"12","key":"ppat.1013018.ref037","doi-asserted-by":"crossref","first-page":"e8294","DOI":"10.1371\/journal.pone.0008294","article-title":"Ethacrynic acid exhibits selective toxicity to chronic lymphocytic leukemia cells by inhibition of the Wnt\/beta-catenin pathway","volume":"4","author":"D Lu","year":"2009","journal-title":"PLoS One"},{"issue":"7793","key":"ppat.1013018.ref038","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41586-020-1951-3","article-title":"Systemic HIV and SIV latency reversal via non-canonical NF-\u03baB signalling in vivo","volume":"578","author":"CC Nixon","year":"2020","journal-title":"Nature"},{"issue":"6","key":"ppat.1013018.ref039","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrm830","article-title":"IAP proteins: blocking the road to death\u2019s door","volume":"3","author":"GS Salvesen","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"ppat.1013018.ref040","doi-asserted-by":"crossref","first-page":"a000158","DOI":"10.1101\/cshperspect.a000158","article-title":"The IKK complex, a central regulator of NF-kappaB activation","volume":"2","author":"A Isra\u00ebl","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"9","key":"ppat.1013018.ref041","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1158\/1078-0432.CCR-12-3151","article-title":"NIK controls classical and alternative NF-\u03baB activation and is necessary for the survival of human T-cell lymphoma cells","volume":"19","author":"L Odqvist","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"9","key":"ppat.1013018.ref042","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1073\/pnas.0707959105","article-title":"Control of canonical NF-kappaB activation through the NIK-IKK complex pathway","volume":"105","author":"B Zarnegar","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"ppat.1013018.ref043","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/cells5010012","article-title":"The Regulation of NF-\u03baB Subunits by Phosphorylation","volume":"5","author":"F Christian","year":"2016","journal-title":"Cells"},{"key":"ppat.1013018.ref044","doi-asserted-by":"crossref","first-page":"11686","DOI":"10.1038\/ncomms11686","article-title":"Stepwise phosphorylation of p65 promotes NF-\u03baB activation and NK cell responses during target cell recognition","volume":"7","author":"H-J Kwon","year":"2016","journal-title":"Nat Commun"},{"issue":"41","key":"ppat.1013018.ref045","doi-asserted-by":"crossref","first-page":"34538","DOI":"10.1074\/jbc.M504943200","article-title":"Phosphorylation of RelA\/p65 on serine 536 defines an I{kappa}B{alpha}-independent NF-{kappa}B pathway","volume":"280","author":"CY Sasaki","year":"2005","journal-title":"J Biol Chem"},{"issue":"11","key":"ppat.1013018.ref046","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nrmicro2223","article-title":"Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs","volume":"7","author":"M Coiras","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"ppat.1013018.ref047","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.3389\/fimmu.2017.01086","article-title":"\u03b2-Catenin directs nuclear factor-\u03baB p65 Output via CREB-binding protein\/p300 in human airway smooth muscle","volume":"8","author":"T Koopmans","year":"2017","journal-title":"Front Immunol"},{"issue":"1","key":"ppat.1013018.ref048","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0092-8674(94)90396-4","article-title":"The ubiquitin-proteasome proteolytic pathway","volume":"79","author":"A Ciechanover","year":"1994","journal-title":"Cell"},{"issue":"7","key":"ppat.1013018.ref049","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1371\/journal.ppat.0030104","article-title":"Regulated degradation of the HIV-1 Vpu protein through a betaTrCP-independent pathway limits the release of viral particles","volume":"3","author":"E Estrabaud","year":"2007","journal-title":"PLoS Pathog"},{"issue":"430","key":"ppat.1013018.ref050","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aap9927","article-title":"HIV latency in isolated patient CD4(+) T cells may be due to blocks in HIV transcriptional elongation, completion, and splicing","volume":"10","author":"S Yukl","year":"2018","journal-title":"Sci Transl Med"},{"issue":"7","key":"ppat.1013018.ref051","doi-asserted-by":"crossref","first-page":"6099","DOI":"10.1128\/JVI.73.7.6099-6103.1999","article-title":"Use of real-time PCR and molecular beacons to detect virus replication in human immunodeficiency virus type 1-infected individuals on prolonged effective antiretroviral therapy","volume":"73","author":"SR Lewin","year":"1999","journal-title":"J Virol"},{"issue":"7","key":"ppat.1013018.ref052","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1128\/JCM.00055-08","article-title":"Highly sensitive methods based on seminested real-time reverse transcription-PCR for quantitation of human immunodeficiency virus type 1 unspliced and multiply spliced RNA and proviral DNA","volume":"46","author":"AO Pasternak","year":"2008","journal-title":"J Clin Microbiol"},{"key":"ppat.1013018.ref053","doi-asserted-by":"crossref","first-page":"103241","DOI":"10.1016\/j.ebiom.2021.103241","article-title":"Multiply spliced HIV RNA is a predictive measure of virus production ex vivo and in vivo following reversal of HIV latency","volume":"65","author":"JM Zerbato","year":"2021","journal-title":"EBioMedicine"},{"issue":"1","key":"ppat.1013018.ref054","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1038\/s41467-021-22608-z","article-title":"Selective cell death in HIV-1-infected cells by DDX3 inhibitors leads to depletion of the inducible reservoir","volume":"12","author":"S Rao","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"ppat.1013018.ref055","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12977-018-0392-7","article-title":"Beyond the replication-competent HIV reservoir: transcription and translation-competent reservoirs","volume":"15","author":"AE Baxter","year":"2018","journal-title":"Retrovirology"},{"issue":"7512","key":"ppat.1013018.ref056","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/nature13594","article-title":"Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys","volume":"512","author":"JB Whitney","year":"2014","journal-title":"Nature"},{"issue":"7","key":"ppat.1013018.ref057","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1172\/JCI136227","article-title":"The multifaceted nature of HIV latency","volume":"130","author":"C Dufour","year":"2020","journal-title":"J Clin Invest"},{"issue":"1","key":"ppat.1013018.ref058","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/COH.0b013e32834124fd","article-title":"NF-\u03baB\/Rel: agonist and antagonist roles in HIV-1 latency","volume":"6","author":"JKL Chan","year":"2011","journal-title":"Curr Opin HIV AIDS"},{"issue":"1","key":"ppat.1013018.ref059","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/cr.2010.177","article-title":"Non-canonical NF-\u03baB signaling pathway","volume":"21","author":"S-C Sun","year":"2011","journal-title":"Cell Res"},{"key":"ppat.1013018.ref060","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2147\/JIR.S140188","article-title":"Mechanisms of NF-\u03baB p65 and strategies for therapeutic manipulation","volume":"11","author":"S Giridharan","year":"2018","journal-title":"J Inflamm Res"},{"issue":"10","key":"ppat.1013018.ref061","first-page":"6137","article-title":"NF-kappa B subunit-specific regulation of the interleukin-8 promoter","volume":"13","author":"C Kunsch","year":"1993","journal-title":"Mol Cell Biol"},{"issue":"1","key":"ppat.1013018.ref062","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/2045-3701-4-13","article-title":"Regulation of Wnt\/\u03b2-catenin signaling by posttranslational modifications","volume":"4","author":"C Gao","year":"2014","journal-title":"Cell Biosci"},{"issue":"4","key":"ppat.1013018.ref063","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1128\/JVI.06266-11","article-title":"Role of \u03b2-catenin and TCF\/LEF family members in transcriptional activity of HIV in astrocytes","volume":"86","author":"S Narasipura","year":"2012","journal-title":"J Virol"},{"issue":"7","key":"ppat.1013018.ref064","doi-asserted-by":"crossref","first-page":"e1005066","DOI":"10.1371\/journal.ppat.1005066","article-title":"Synergistic reactivation of latent HIV expression by ingenol-3-angelate, PEP005, targeted NF-kB signaling in combination with JQ1 induced p-TEFb activation","volume":"11","author":"G Jiang","year":"2015","journal-title":"PLoS Pathog"}],"updated-by":[{"DOI":"10.1371\/journal.ppat.1013018","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000}}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1013018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T13:42:17Z","timestamp":1744724537000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1013018"}},"subtitle":[],"editor":[{"given":"Edward M","family":"Campbell","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":64,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1013018","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,1]]}}}